STVN

NYSE Healthcare

Stevanato Group S.p.A. Ordinary Shares

Medical Instruments & Supplies

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions; drug delivery systems, including pen injectors, auto-injectors, and wearable injectors; diagnostic laboratory consumables; analytical and regulatory support services; medical devices; pharmaceutical visual inspection machines; assembling and packaging machines; glass converting machines; and after-sales services, such as line optimization and line conversions, training, logistics, spare parts and maintenance services. It also provides contract development and manufacturing services for customer-owned drug delivery devices. The company serves pharmaceutical, biotechnology, diagnostics, and life sciences companies; and drug products, glass packaging, and fill and finish contract manufacturers. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.

๐Ÿ“Š Market Data
Price$17.71
Volume485,456
Market Cap4.83B
Dividend Yield %0.35%
Beta0.620
RSI (14-Day)88.2 Overbought
200-Day MA$20.67
50-Day MA$15.07
52-Week High$28.00
52-Week Low$12.89
P/E Ratio29.52
Forward P/E20.72
Price / Book2.78
๐ŸŽฏ Investment Strategy Scores

STVN scores across each investment strategy. Higher is better for that strategy's goals.

High dividend yield + low volatility
๐Ÿš€ Moon Shot 9/100โ–ผ -1
High growth potential (high beta + oversold)
๐Ÿ”ช Falling Knife 33/100โ–ผ -10
Contrarian plays (oversold + below moving average)
๐ŸŽˆ Over-Hyped 98/100โ€” 0
Overbought stocks (potential short candidates)
Large-cap, institutional-quality stocks
๐Ÿ” Strategy Interpretation

Best fit: ๐ŸŽˆ Over-Hyped (98/100) โ€” this strategy Overbought stocks (potential short candidates).

Lowest fit among scored strategies: ๐Ÿš€ Moon Shot (9/100). No single score is a buy or sell signal โ€” use multiple lenses together. Learn how to read these scores โ†’

Find STVN in your text

Paste any article, transcript, or post โ€” the tool will extract STVN and every other hidden ticker.

Try the Ticker Extractor โ†’

Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-05-01.